Ilsung Pharmaceuticals Co., Ltd. (003120.KS)

KRW 15970.0

(-0.19%)

Total Debt Summary of Ilsung Pharmaceuticals Co., Ltd.

  • Ilsung Pharmaceuticals Co., Ltd.'s latest annual total debt in 2023 was 238.12 Million KRW , down -13.2% from previous year.
  • Ilsung Pharmaceuticals Co., Ltd.'s latest quarterly total debt in 2024 Q1 was 232.57 Million KRW , down -2.33% from previous quarter.
  • Ilsung Pharmaceuticals Co., Ltd. reported annual total debt of 274.35 Million KRW in 2022, up 51.52% from previous year.
  • Ilsung Pharmaceuticals Co., Ltd. reported annual total debt of 181.06 Million KRW in 2021, down -58.99% from previous year.
  • Ilsung Pharmaceuticals Co., Ltd. reported quarterly total debt of 232.57 Million KRW for 2024 Q1, down -2.33% from previous quarter.
  • Ilsung Pharmaceuticals Co., Ltd. reported quarterly total debt of 238.12 Million KRW for 2023 Q4, down -15.88% from previous quarter.

Annual Total Debt Chart of Ilsung Pharmaceuticals Co., Ltd. (2023 - 2007)

Historical Annual Total Debt of Ilsung Pharmaceuticals Co., Ltd. (2023 - 2007)

Year Total Debt Total Debt Growth
2023 238.12 Million KRW -13.2%
2022 274.35 Million KRW 51.52%
2021 181.06 Million KRW -58.99%
2020 441.5 Million KRW 249.01%
2019 126.5 Million KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%
2015 - KRW 0.0%
2014 - KRW 0.0%
2013 - KRW -100.0%
2012 1.5 Billion KRW -57.14%
2011 3.5 Billion KRW -30.0%
2010 5 Billion KRW 66.67%
2009 3 Billion KRW 0.0%
2008 - KRW 0.0%
2007 - KRW 0.0%

Peer Total Debt Comparison of Ilsung Pharmaceuticals Co., Ltd.

Name Total Debt Total Debt Difference
Dongwha Pharm.Co.,Ltd 48.25 Billion KRW 99.507%
Yuhan Corporation 230.07 Billion KRW 99.896%
Yuhan Corporation 230.07 Billion KRW 99.896%
Yuyu Pharma, Inc. 39.4 Billion KRW 99.396%
Yuyu Pharma, Inc. 39.4 Billion KRW 99.396%
Yuyu Pharma, Inc. 39.4 Billion KRW 99.396%
Ildong Holdings Co., Ltd. 382.06 Billion KRW 99.938%
Samil Pharmaceutical Co.,Ltd 175.87 Billion KRW 99.865%
Dong-A Socio Holdings Co., Ltd. 691.88 Billion KRW 99.966%
JW Pharmaceutical Corporation 170.28 Billion KRW 99.86%
JW Pharmaceutical Corporation 170.28 Billion KRW 99.86%
JW Pharmaceutical Corporation 170.28 Billion KRW 99.86%
SAMSUNG PHARM. Co., LTD. 595.48 Million KRW 60.011%
Chong Kun Dang Holdings Corp. 468.03 Billion KRW 99.949%
Dong Sung Bio Pharm.Co.,Ltd. 43.27 Billion KRW 99.45%
HANDOK Inc. 300.01 Billion KRW 99.921%
Jeil Pharma Holdings Inc 173.03 Billion KRW 99.862%
Kukje Pharma Co., Ltd. 30.66 Billion KRW 99.223%
Bukwang Pharmaceutical Co., Ltd. 79.38 Billion KRW 99.7%
Aprogen pharmaceuticals,Inc. 180.99 Billion KRW 99.868%
Daewon Pharmaceutical Co., Ltd. 146.04 Billion KRW 99.837%
Yungjin Pharm. Co., Ltd. 66.88 Billion KRW 99.644%
Boryung Corporation 204.21 Billion KRW 99.883%
Hyundai Pharmaceutical Co., Ltd. 39.2 Billion KRW 99.393%
Samjin Pharmaceuticals Co., Ltd. 118.63 Billion KRW 99.799%
Ilyang Pharmaceutical Co.,Ltd 85.15 Billion KRW 99.72%
Ilyang Pharmaceutical Co.,Ltd 85.15 Billion KRW 99.72%
Suheung Co., Ltd. 467.85 Billion KRW 99.949%
Kwang Dong Pharmaceutical Co., Ltd. 235.64 Billion KRW 99.899%
Hanall Biopharma Co.,Ltd 1.29 Billion KRW 81.548%
Whan In Pharm Co.,Ltd. 632.02 Million KRW 62.323%
MYUNGMOON Pharm co.,Ltd 90.48 Billion KRW 99.737%
Shin Poong Pharm.Co.,Ltd. 46.15 Billion KRW 99.484%
Shin Poong Pharm.Co.,Ltd. 46.15 Billion KRW 99.484%
Korea United Pharm Inc. 40.33 Billion KRW 99.41%
CKD Bio Corp. 146.92 Billion KRW 99.838%
Daewoong pharmaceutical Co.,Ltd 469.68 Billion KRW 99.949%
JW Holdings Corporation 554.58 Billion KRW 99.957%
REYON Pharmaceutical Co., Ltd. 225.05 Billion KRW 99.894%
Hanmi Pharm. Co., Ltd. 572.86 Billion KRW 99.958%
Dong-A ST Co., Ltd. 406.7 Billion KRW 99.941%
Chong Kun Dang Pharmaceutical Corp. 219.76 Billion KRW 99.892%
JW Lifescience Corporation 46.31 Billion KRW 99.486%
Ildong Pharmaceutical Co., Ltd. 217.84 Billion KRW 99.891%
Jeil Pharmaceutical Co.,Ltd 84.96 Billion KRW 99.72%
Hana Pharm Co., Ltd. 26.53 Billion KRW 99.103%